Ledger.Open graph →
SEC Form D · filed May 8, 2020

Viridian Therapeutics, Inc

Offering
$5.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Tomas Kiselak · Waltham, MADirectorPeter Harwin · Waltham, MADirectorJonathan Violin · Waltham, MAExec · DirectorSteve Gallo · Louisville, KYDirectorHeather K. Goodman · San Francisco, CAExec · DirectorBen Streepey · Louisville, KYDirectorCamille Samuels · San Diego, CAExec · DirectorJack Nielsen · San Diego, CADirectorJeffrey Pentland · Toronto, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗